Aggregation properties of a polymeric anticancer therapeutic: A coarse-grained modeling study

Journal of Chemical Information and Modeling

Volumn 51, Issue 12, 2011, Pages 3030-3035

  Peng, Lili X ^a   Yu, Lei ^c   Howell, Stephen B ^b   Gough, David A ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c Biomedical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR DYNAMICS;

AGGREGATION PROPERTY; COARSE GRAINED MODELS; COARSE-GRAINED MOLECULAR DYNAMICS; PACLITAXEL;

FUNCTIONAL POLYMERS;

ANTINEOPLASTIC AGENT; DRUG CARRIER; DRUG DERIVATIVE; PACLITAXEL; POLY(GAMMA GLUTAMYLGLUTAMINE)PACLITAXEL; POLY(GAMMA-GLUTAMYLGLUTAMINE)PACLITAXEL; PROTEIN;

CHEMISTRY; CONFORMATION; LETTER; MOLECULAR DYNAMICS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG CARRIERS; MOLECULAR CONFORMATION; MOLECULAR DYNAMICS SIMULATION; PACLITAXEL; PROTEINS;

EID: 84555194746     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci200214m     Document Type: Article

References (33)

1. Amiji, M. M. Nanotechnology for cancer therapy; CRC Press: Boca Raton, FL, 2007; Vol. 1, p 817.
2. Ferrari, M. Cancer nanotechnology: opportunities and challenges Nat. Rev. 2005, 5, 161-171
3. Cho, K.; Wang, X.; Nie, S.; Chen, Z.; Shin, D. M. Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 2008, 14, 1310-1316
4. Adiseshaiah, P. P.; Hall, J. B.; McNeil, S. E. Nanomaterial standards for efficacy and toxicity assessment Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2009, 2, 99-112
5. Jain, R.; Stylianopoulos, T. Delivering nanomedicine to solid tumors Nat. Rev. Clin. Oncol. 2010, 7, 653-664
6. Buzea, C.; Pacheco, I. I.; Robbie, K. Nanomaterials and nanoparticles: sources and toxicity Biointerphases 2007, 2, 17-71
7. Jiang, J.; Oberdorster, G.; Biswas, P. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies J. Nanopart. Res. 2009, 1, 77-89
8. Oberdorster, G.; Stone, V.; Donaldson, K. Toxicology of nanoparticles: a historical perspective Nanotoxicology 2007, 1, 2-25
9. Moos, P. J.; Chung, K.; Woessner, D.; Honeggar, M.; Cutler, N. S.; Veranth, J. M. ZnO particular matter requires cell contact for toxicity in human colon cancer cells Chem. Res. Toxicol. 2010, 23, 733-739
10. Pan, Y.; Neuss, S.; Leifert, A.; FIschler, M.; Wen, F.; Simon, U.; Schmid, G.; Brandau, W.; Jahnen-Dechent, W. Size-dependent cytotoxicity of gold nanoparticles Small 2007, 3, 1941-1949
11. van Gunsteren, W. F. Molecular dynamics studies of proteins Curr. Opin. Struct. Biol. 1993, 3, 277-281
12. Ng, R. Drugs: From Discovery to Approval; John Wiley & Sons, Inc.: Hoboken, NJ, 2004.
13. Wang, X.; Zhao, G.; Van, S.; Yu, L. Polymer paclitaxel conjugates and methods for treating cancer 2009, not supplied.
14. Vitalis, A.; Lyle, N.; Pappu, R. V. Thermodynamics of beta-sheet formation in polyglutamine Biophys. J. 2009, 97, 303-311
15. Bellesia, G.; Shea, J-E Self-assembly of beta-sheet forming peptides into chiral fibrillar aggregates J. Chem. Phys. 2007, 126, 245104-245111
16. Caflisch, A. Computational models for the prediction of polypeptide aggregation propensity Curr. Opin. Chem. Biol. 2006, 10, 437-444
17. Pellarin, R. C.A. Interpreting the aggregation kinetics of amyloid peptides J. Mol. Biol. 2006, 360, 882-892
18. Monsellier, E.; Ramazzotti, M.; Taddei, N.; Chiti, F. Aggregation propensity of the human proteome PLoS Comput. Biol. 2008, 4, 1-9
19. Bratko, D.; Cellmer, T.; Prausnitz, J. M.; Blanch, H. W. Molecular simulation of protein aggregation Biotechnol. Bioeng. 2007, 96, 1-8
20. Chennamsetty, N.; Voynov, V.; Kayser, V.; Helk, B; Trout, B. L. Design of therapeutic proteins with enhanced stability Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 11937-11942
21. de Groot, N. S.; Pallares, I.; Aviles, F. X.; Vendrell, J.; Ventura, S., Prediction of "hot spots" of aggregation in disease-linked polypeptides. BMC Struct. Biol. 2005, 5.
22. Ma, B.; Nussinov, R. Simulations as analytical tools to understand protein aggregation and predict amyloid conformation Curr. Opin. Chem. Biol. 2006, 10, 445-452
23. Nichols, G.; Byard, S.; Bloxham, M. J.; Botterill, J.; Dawson, N. J.; Dennis, A.; Diart, V.; North, N. C.; Sherwood, J. D. A review of the terms agglomerate and aggregate with a recommendation for nomenclature used in powder and particle characterization J. Pharm. Sci. 2002, 91, 2103-2109
24. Peng, L. X.; Ivetac, A.; Chaudhari, A. S.; Van, S.; Zhao, G.; Yu, L.; Howell, S. B.; McCammon, J. A.; Gough, D. A. Characterization of a clinical polymer-drug conjugate using multiscale modeling Biopolymers 2010, 93, 935-951
25. Marrink, S. J.; de Vries, A. H.; Mark, A. E. Coarse-grained model for semi-quantitative lipid simulations J. Phys. Chem. B 2004, 108, 750-760
26. Marrink, S. J.; Rissalada, J. H.; Yefimov, S.; Tieleman, D. P.; de Vries, A. H. The MARTINI force field: coarse-grained model for biomolecular simulations J. Phys. Chem. B 2007, 111, 7812-7824
27. Monticelli, L.; Kandasamy, S. K.; Periole, X.; Larson, R. G.; Tieleman, D. P.; Marrink, S. J. The MARTINI coarse-grained force field: extension to proteins J. Chem. Theory Comput. 2008, 4, 819-834
28. Schlick, T. Molecular Modeling and Simulation: An Interdisciplinary Guide; Springer: New York, NY, 2002; Vol. 21.
29. Peng, L. X.; Das, S. K.; Yu, L.; Howell, S. B.; Gough, D. A., Coarse-grained modeling study of nonpeptide RGD ligand density and PEG molecular weight on the conformation of poly(gamma-glutamyl-glutamate) paclitaxel conjugates. J. Mol. Model. 2011.
30. Humphrey, W.; Dalke, A.; Schulten, K. VMD-Visual Molecular Dynamics J. Mol. Graphics 1996, 14, 33-38
31. MathWorks; Natick, MA, 1994 - 2008.
32. Cass, M. J.; Heyes, D. M. Brownian dynamics simulations of associating diblock copolymers Langmuir 2007, 23, 6576-6587
33. Nowicki, W.; Nowicka, G. Model of aggregation of colloidal fine particles in the presence of supersized polymer Colloid Polym. Sci. 1995, 273, 298-305